LEP and obesity due to melanocortin 4 receptor deficiency: The ability of boosting the leptin level and reducing the lipid metabolism by the high-dose spirulina implicates the potential therapeutic application for clinical obesity management (Carlier et al., 2010; Brown et al., 2014; Coello et al., 2019).